Director, Abgentis Limited, Abingdon, Oxon, UK
I have been involved in antibacterial R&D for 15-years, specialising in cell divison inhibitors (Fts Z) & DNA supercoiling (GyrB/ParE). After building up and even selling an antibacterial biotech (2001-2011), I started my own antibacterial biotech – Abgentis Limited to re-engineer aminocoumarin antibiotics. I also consult via Chemical Biology Ventures Limited. I have worked with MRC, BBSRC & Wellcome Trust funding previously and was a member of the BSAC Urgent Need group.